Redian新闻
>
Nature也提供grant的申请
avatar
Nature也提供grant的申请# Faculty - 发考题
t*r
1
http://www.nature.com/openinnovation?challengeId=9933671
nature.com has teamed up with InnoCentive to offer its readers the
opportunity to participate in research and development challenges. As a
Solver, you can apply your expertise to important problems, stretch your
creative boundaries, and win cash awards.
Markers of Transduction and Gene Expression Compatible with Ocular Gene
Therapy
Challenge Status: UNDER EVALUATION Challenge Type: Theoretical-licensing
INNOCENTIVE: 9933643
The concept of gene therapy arose decades ago, when researchers postulated
that human diseases could be treated by using a technique to introduce
foreign DNA to correct genetic defects and disease phenotypes. In recent
years, advances in gene therapy have been documented in the treatment of
genetic disorders, cancer, and neurodegenerative diseases. Inherited
diseases such as retinitis pigmentosa are among a handful of ocular diseases
that are amenable to gene therapy. The Seeker desires solutions that will
both qualitatively and (semi-) quantitatively measure in vivo gene
expression in human ocular tissues.
This Challenge requires only a written proposal.
Read more at InnoCentive
DEADLINE: Jun 20 2015 Project Rooms Challenge Posted: Apr 21 2015
Create Accessories to Enhance the Driving Experience
Challenge Status: UNDER EVALUATION Challenge Type: Ideation INNOCENTIVE:
9933613
Vehicles traveling in remote regions or through rugged terrain have unique
durability requirements and often experience delays in obtaining replacement
parts. Sparse population densities require self-sufficiency in instances of
mechanical or electrical failure, hazardous weather, and other situations.
Ford is searching for novel designs of accessories and the underlying
process of coming up with solutions when driving in remote areas. To make
the challenge realistic we are setting the challenge in Australia.
This is an Ideation Challenge with a guaranteed award for at least one
submitted solution.
相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。